Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitrous Oxide for Acute Suicidality and Depression in the Emergency Department
NCT05710887Phase 2Withdrawn
- Sponsor
- University of Chicago
- Start
- Feb 2026
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitrous oxide in suicidal ideation, major depressive disorder (MDD), sponsored by University of Chicago. Planned start Feb 2026; status: withdrawn.
02
Drugs
nitrous oxide
03
Conditions
suicidal ideationmajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05710887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05710887.